Navigation Links
Preclinical Study Examines Use of nContact's Technology in Enabling a Percutaneous Device Approach to Epicardial Ablation
Date:2/23/2012

MORRISVILLE, N.C., Feb. 23, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced that a new preclinical study examines a unique minimally invasive percutaneous approach to accessing the heart that may enable electrophysiologists (EPs) to perform epicardial ablation for ventricular tachycardia (VT). The study was published in the February 2012 issue of The Journal of Innovations in Cardiac Rhythm Management.

In the study, "Creating Transmural, Linear Epicardial Ablation Lesions via a Non-surgical, Percutaneous, Subxyphoid, Electrogram-guided Approach," researchers sought to modify an existing epicardial ablation device's (nContact's EPi-Sense® Guided Coagulation Device with VisiTrax®) transdiaphragmatic approach to a percutaneous subxyphoid (below the sternum) approach that could enable epicardial ablation without requiring a more invasive surgical access. The EPi-Sense® system has been used clinically in Europe for the treatment of atrial fibrillation and investigators in this study suggest it may also be suitable for the treatment of sinus tachycardia and challenging VT. 

"In this study, we examined for the first time a truly minimally invasive, 'incisionless' approach to performing epicardial ablation. Clinical experience has shown that VT and other arrhythmias originating on the epicardial aspect of the heart may not respond to endocardial ablation, suggesting the need for less invasive tools designed to create lesions on the epicardium," said lead investigator Miguel Valderrabano, MD, FACC of The Methodist Hospital, Houston, TX. "While further studies are needed on the applicability of this technique in clinical electrophysiology, our findings suggest it may expand the capabilities of EP-guided ablation and offer promising clinical utility in addressing VT."

For this preclinical study, researchers performed epicardial ablation on six pigs with a
'/>"/>

SOURCE nContact, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
6. Isis Reports Preclinical Data Supporting Liver Safety of ISIS 301012
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
9. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
10. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
11. CorNova Preclinical Results of Valecor Platinum(TM) Coronary Stent Studies Presented at TCT 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3,  2015 About ... bio-artificial devices, which are implanted or integrated ... organs. These include artificial heart, kidney, pancreas, ... polymers (polyurethane, polysulfone, and porous polypropylene), biologics, ... artificial organs. These organs are incorporated with ...
(Date:9/3/2015)... About dry eye syndrome Dry eye syndrome usually ... production or quick tear evaporation or deviation in tear ... deficient dry eye and evaporative dry eye. In aqueous ... enough tears, whereas meibomian gland dysfunction results in evaporative ... evaporation and maintain tear stability. The symptoms include pain, ...
(Date:9/3/2015)... Denmark , Sept. 3, 2015 /PRNewswire/ ... a clinical stage biotechnology company that applies ... unmet medical needs, today announced plans to ... 2015 Wells Fargo Healthcare Conference in BostonDate: ... EDTEvent: , Bank of America Merrill Lynch ...
Breaking Medicine Technology:Global Artificial Organ Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2
(Date:9/4/2015)... ... 2015 , ... With TransCel from Pixel Film Studios users can simulate celluloid ... With TransCel users have full control over camera position and angle within 3D space ... inner color, text, and more. With TransCel the possibilities are endless. , Users have ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... The Schmidt ... of Tanya De La Paz. , Schmidt National Law Group, a leading firm ... District of California against Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates for ...
(Date:9/4/2015)... , ... September 04, 2015 , ... IVF New England, ... a New Hampshire fertility "ManchVegas Happy Hour" in Manchester for women who wish to ... 2015 at XO on Elm restaurant and lounge, 827 Elm Street, Manchester, NH from ...
(Date:9/4/2015)... ... , ... After wearing the same uniforms for six seasons, the Sprayberry High ... to assist the team, the Jones Agency, a locally owned insurance firm that serves ... the new uniforms. , As is so often the case with high school and ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... out to benefit Core Compassion Project. Core Compassion Project is a non-profit ... program to reduce the side effects of cancer treatments and recover their mobility, ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2
... , , , ... BOSTON, Aug. 10 PAREXEL International Corporation (Nasdaq: ... Year ended June 30, 2009. The Company has determined the need ... described in greater detail below. These changes relate to (1) the ...
... ... advising sufferers of Seasonal Affective Disorder (SAD), a condition that usually affects people during the ... keep symptoms of SAD at bay. , ... Cambridge (PRWeb UK) August 10, 2009 -- Based on light measurements taken for ...
... N.J., Aug. 10 Pharmasset, Inc. (Nasdaq: VRUS ), ... novel drugs to treat viral infections, today reported financial results and ... , , Financial Results , ... June 30, 2009 compared to $0.5 million for the quarter ended ...
... TSX: COM, , , VANCOUVER, Aug. 10 /PRNewswire-FirstCall/ ... a teleconference call and webcast will be held at 9:00am ... 2009 second quarter financial results. , To access the conference ... There will be a separate dial-in line for analysts on ...
... , , Increased caseloads, ... concerns , , WASHINGTON, Aug. 10 ... approximately 4,000 HIV-treating clinicians in the United States [out of a ... survey indicating that while supportive of ongoing health care reform efforts, ...
... 10 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International Limited (NYSE: MR ), ... its selected unaudited,financial results for the second quarter and first half ... Second Quarter and First Half 2009, -- Second ... 9.9% over the second quarter of ...
Cached Medicine News:Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 2Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 3Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 4Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 5Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 6Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 7Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 8Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 9Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 10Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 11Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 12Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 13Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 14Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 15Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 16Health News:PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 17Health News:Lumie Reveals Light Levels Received In July Are As Low As A Winter's Day 2Health News:Lumie Reveals Light Levels Received In July Are As Low As A Winter's Day 3Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 2Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 3Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 4Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 5Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 6Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 7Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 8Health News:Cardiome to Hold Conference Call 2Health News:Cardiome to Hold Conference Call 3Health News:HIV-Treating Clinicians Support Health Care Reform, Express Caution 2Health News:HIV-Treating Clinicians Support Health Care Reform, Express Caution 3Health News:HIV-Treating Clinicians Support Health Care Reform, Express Caution 4Health News:HIV-Treating Clinicians Support Health Care Reform, Express Caution 5Health News:Mindray Announces Second Quarter 2009 Financial Results 2Health News:Mindray Announces Second Quarter 2009 Financial Results 3Health News:Mindray Announces Second Quarter 2009 Financial Results 4Health News:Mindray Announces Second Quarter 2009 Financial Results 5
... Knee System has been ... refined with the aid ... and manufacturing technology. Its ... stability, function, performance and ...
... Iso-C3D C-Arm imaging system interface sets a ... C-arm imaging. Combining mobility and accurate ... cooperative technologies deliver the most complete perspective ... is the new standard in the OR. ...
... mobile imaging just got better with ... instrumentation. Now using,your C-arm you can ... Add Visualization and Navigation Technology, ... Decision Making, Provide a Platform ...
... Asteion Multi puts the most advanced ... types of institutions, because it offers many ... Aquilion, but in a value-oriented platform. Asteion ... the high-throughput of multi-slice scanning, while also ...
Medicine Products: